Function dyspepsia
Conditions
Interventions
Needling manipulation 1:Lifting-inserting needling manipulations with 1 times/s
Needling manipulation 2:Lifting-inserting needling manipulations with 2 times/s
Needling manipulation 3:Lifting-inserting needling manipulations with 3 times/s
Control group:Omeprazole
Sponsors
Zhejiang Provincial Hospital of TCM
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals who meet the Rome III FD criteria, and within a subgroup of epigastric pain syndrome (EPS); 2. Individuals between the ages of 18 and 60 years; 3. Individuals who receive no other treatments during the study; 4. Individuals who voluntarily agree with a study protocol and sign a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Individuals unwilling to sign the informed consent; 2. Individuals who have serious structural disease (disease of heart, lung, liver, kidney, digestive system or hematopoietic system ) or mental illness; 3. Individuals with other diseases that could interfere with acupuncture treatment, e.g., clotting disorders or leukopenia, pace-maker, epilepsy, or anticoagulant therapy; 4. Individuals who are pregnant or breastfeeding; 5. Individuals who have difficulties in attending the trial (e.g., paralysis, cancer, dementia, drug addiction, time constraint, surgical operation).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nepean Dyspepsia Index;36-itemShort-form Heath Survey;Self-rating depression scale;Self-Rating Anxiety Scale ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Motilin;Gastrin;Ghrelin; | — |
Countries
China
Contacts
Public ContactShouhai Hong
Zhejiang Provincial Hospital of TCM
Outcome results
None listed